Skip to content

News & Events

Explore our latest news, insights, and events.

RadNet’s DeepHealth Announces Wichita Radiological Group as First Operations Suite™ Customer

RadNet’s DeepHealth Announces Wichita Radiological Group as First Operations Suite™ Customer

SOMERVILLE, Mass. (November 20, 2025) — DeepHealth, a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a leader in AI-powered health informatics, today announced Wichita Radiological Group (WRG) has selected DeepHealth’s Operations Suite™1 to replace its legacy Radiology Information System (RIS) to advance operations, strengthen care coordination and deliver a more connected, patient-centered imaging experience across its multi-site network.

Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth’s Novel AI-Powered Breast Cancer Detection Workflow

Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth’s Novel AI-Powered Breast Cancer Detection Workflow

LOS ANGELES and SOMERVILLE, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), the nation’s largest provider of outpatient diagnostic imaging services, and its wholly owned subsidiary, DeepHealth, a global leader in AI-powered health informatics, today announced results from the largest real-world analysis of AI-driven breast cancer screening ever conducted in the United States.1

GE HealthCare and RadNet’s DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning

GE HealthCare and RadNet’s DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning

Los Angeles – Nov. 12, 2025 – Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced their intention to expand their existing strategic collaboration to further the innovation, commercialization and adoption of AI across multiple imaging modalities.

RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening

RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening

LOS ANGELES and LONDON, November 11, 2025 — RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a US leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced today the acquisition of CIMAR UK, a leading provider of cloud-native healthcare image management solutions.

RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT’s Assets

RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT’s Assets

LOS ANGELES, November 5, 2025 — RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a US leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced it has acquired the assets of Alpha RT, a pioneer in remote MRI scanning solutions and services.

DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™

DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™

Somerville, MA, – August 7, 2025, DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and global leader in AI-powered health informatics, announced today that it has received FDA 510(k) clearance for TechLive™ – a remote scanning solution enabling centralized operation and supervision of MR, CT, PET/CT, and Ultrasound procedures.

RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD

RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD

Los Angeles, CA – July 17, 2025, RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced today that it has completed the acquisition of iCAD, Inc. (NASDAQ: ICAD) (“iCAD”), a global leader in AI-powered breast health solutions.

RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics

RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics

Los Angeles, CA – June 4, 2025, RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions through its wholly-owned subsidiary DeepHealth, announced today that it has completed the acquisition of See-Mode Technologies PTE LTD (“See-Mode”), a global innovator in AI for ultrasound imaging.

RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer

RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer

Los Angeles, CA and Nashua, NH – April 15, 2025, RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, and iCAD, Inc. (NASDAQ: ICAD) (“iCAD”), a global leader in providing clinically proven AI-powered breast health solutions, announced today that they have entered into a definitive merger agreement under which RadNet will acquire iCAD in an all stock transaction.

DeepHealth Introduces New AI-Powered Radiology Informatics and Population Screening Solutions at #ECR2025

DeepHealth Introduces New AI-Powered Radiology Informatics and Population Screening Solutions at #ECR2025

Vienna, Austria, 26 February 2025 – DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), will introduce next-generation AI-powered radiology informatics and population screening solutions at the European Congress of Radiology (ECR) 2025 in Vienna. With the aim of empowering breakthroughs in care enabled by imaging, DeepHealth’s suite of solutions addresses critical clinical and operational challenges experienced by healthcare providers around the world.

RadNet’s Wholly-Owned Subsidiary, DeepHealth, and ConcertAI’s TeraRecon Announce Strategic Collaboration Around Integrated AI and Advanced Visualization

RadNet’s Wholly-Owned Subsidiary, DeepHealth, and ConcertAI’s TeraRecon Announce Strategic Collaboration Around Integrated AI and Advanced Visualization

Los Angeles, CA/Somerville, MA, February 25, 2025 – DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT) and ConcertAI’s TeraRecon, a leader in medical imaging advanced visualization, clinical AI, and workflow automation, announced today a strategic collaboration to integrate certain capabilities to advance imaging tools and the radiology workflow.

RadNet’s Wholly-Owned Subsidiary, DeepHealth, Launches New AI-powered Informatics and SmartTechnology™ Innovations at #RSNA2024

RadNet’s Wholly-Owned Subsidiary, DeepHealth, Launches New AI-powered Informatics and SmartTechnology™ Innovations at #RSNA2024

Los Angeles, CA/Somerville, MA, December 2, 2024 – DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), has launched new AI-powered solutions at RSNA 2024. These solutions enable breakthroughs in imaging-based diagnosis, population health screening programs, and efficient large-scale imaging operations.

Siemens Healthineers and RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™

Siemens Healthineers and RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™

December 1, 2024 – Siemens Healthineers and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today announced a strategic collaboration aimed at transforming ultrasound operations through the implementation of SmartTechnology™ by embedding AI-powered health informatics within workflows and imaging hardware.

RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai’s Platform to Develop a New AI Control System for Clinical AI Performance and Safety

RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai’s Platform to Develop a New AI Control System for Clinical AI Performance and Safety

Los Angeles, CA/Somerville, MA, December 1, 2024 – DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced a strategic collaboration with CARPL.ai, a leading AI orchestration company that enables radiologists to access, assess, and integrate radiology AI solutions in their workflows.

RadNet’s DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution

RadNet’s DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution

Somerville, MA, November 29, 2024 – DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-powered health informatics, has received expanded FDA 510(k) clearance for its innovative mammography software. SmartMammo Dx, the AI algorithm within SmartMammo1, is now FDA-cleared to be compatible with GE HealthCare’s Senographe Pristina™ mammography systems.